205 related articles for article (PubMed ID: 5378265)
1. [Chlorpropamide-metformin in obese diabetic patients or with secondary response failure to sulfonylureas].
Garcia Viveros M; Lozano Castañeda O; Quibrera Infante R; Rull JA
Prensa Med Mex; 1969; 34(9):391-6. PubMed ID: 5378265
[No Abstract] [Full Text] [Related]
2. [Chlorpropamide-metformin in obese diabetics or diabetics with side effects from sulfonylureas. 2-year results].
Garcia Viveros M; Prado Vega R; Rull JA; Lozano-Castañeda O
Prensa Med Mex; 1971; 36(7):347-9. PubMed ID: 5096256
[No Abstract] [Full Text] [Related]
3. [Chlorpropamide-metformin in obese diabetics or diabetics with secondary failure of response to sulfonylureas].
Gonzalez Millan H; Quibrera Infante R; Rull JA; Lozano Castaneda O
Prensa Med Mex; 1968; 33(11):465-72. PubMed ID: 5760092
[No Abstract] [Full Text] [Related]
4. [Treatment of diabetes mellitus with metformin].
Parrow A
Lakartidningen; 1968 Nov; 65(47):4671-6 passim. PubMed ID: 5742151
[No Abstract] [Full Text] [Related]
5. [Long-term (3 year) results of the treatment of stable diabetes with low doses of chlopropamide-metformin].
Schulte J; García Viveros M; Rull J; Lozano-Castañeda O
Prensa Med Mex; 1973; 38(7):281-2. PubMed ID: 4789184
[No Abstract] [Full Text] [Related]
6. [Round-table discussion on the value of the association of chlorpropamide with metformin in the treatment of diabetes mellitus].
J Med Lyon; 1972 Feb; 53(222):153-6 passim. PubMed ID: 5046640
[No Abstract] [Full Text] [Related]
7. [Clinico-statistical studies of the use of oral hypoglycemic agents in the therapy of diabetes: critical evaluation of their effectiveness and tolerance].
Torri A; Zanni A; Roncaia R; Di Saverio S
Clin Ter; 1977 Jul; 82(1):45-56. PubMed ID: 409583
[No Abstract] [Full Text] [Related]
8. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
[TBL] [Abstract][Full Text] [Related]
9. Combination of drugs in the management of diabetes mellitus.
Das S
J Indian Med Assoc; 2002 Jul; 100(7):434, 436, 445-7. PubMed ID: 12674168
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study of a new hypoglycemic agent: Diabiphage].
Linquette M; Fossati P; Decoulx M
Lille Med; 1971; 17():Suppl 3:559-65. PubMed ID: 5153015
[No Abstract] [Full Text] [Related]
11. [4 years of clinical experience with metformin in 47 diabetic patients].
Joncas F
Union Med Can; 1972 Jan; 101(1):65-70. PubMed ID: 5013455
[No Abstract] [Full Text] [Related]
12. [Results obtained with metformin in cases not responding to chlorpropamide].
Ipbüker A
Turk Tip Cemiy Mecm; 1965 Jul; 31(7):358-69. PubMed ID: 5852769
[No Abstract] [Full Text] [Related]
13. Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.
Ravipati G; Aronow WS; Ahn C; Sujata K; Saulle LN; Channamsetty V; Weiss MB
Am J Ther; 2006; 13(5):400-3. PubMed ID: 16988534
[TBL] [Abstract][Full Text] [Related]
14. Oral treatment of diabetes mellitus.
Chhetri MK
J Indian Med Assoc; 1968 May; 50(10):486-8. PubMed ID: 4883853
[No Abstract] [Full Text] [Related]
15. Comparison of chlorpropamide and metformin treatment on weight and blood-glucose response of uncontrolled obese diabetics.
Clarke BF; Duncan LJ
Lancet; 1968 Jan; 1(7534):123-6. PubMed ID: 4169605
[No Abstract] [Full Text] [Related]
16. [Comparison between the action of chlorpropamide and an association of chlorpropamide with metformin on the daily fluctuations of glucose and insulin in diabetics].
Berger W; Goschke H; Denes A
J Med Lyon; 1972 Feb; 53(222):168 passim. PubMed ID: 5046641
[No Abstract] [Full Text] [Related]
17. Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes.
Fanghänel G; Silva U; Sanchez-Reyes L; Sisson D; Sotres D; Torres EM
Rev Invest Clin; 1998; 50(5):389-94. PubMed ID: 9949668
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of glibenclamide and chlorpropamide. (Preliminary report).
Hamblin JJ; Ismay G; Good MS; Wynne-Williams CJ; Baum G; Wilson IV
Postgrad Med J; 1970 Dec; ():Suppl:92-4. PubMed ID: 5533305
[No Abstract] [Full Text] [Related]
19. The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients.
Ersoy C; Kiyici S; Budak F; Oral B; Guclu M; Duran C; Selimoglu H; Erturk E; Tuncel E; Imamoglu S
Diabetes Res Clin Pract; 2008 Jul; 81(1):56-60. PubMed ID: 18358555
[TBL] [Abstract][Full Text] [Related]
20. [Long range results (5 years) in the treatment of stable diabetes with low doses of clorpropamide-metformin (author's transl)].
Díes H; Lozano Castañeda O; García Viveros M; Schulte J; Figueroa J; Rull JA
Rev Invest Clin; 1978; 30(2):131-4. PubMed ID: 353940
[No Abstract] [Full Text] [Related]
[Next] [New Search]
